Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07231029 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Pharmacokinetic Study of TS-172 in Patients With Hepatic Impairment

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Start date changed from estimate of Dec 2025 to Dec 23, 2025v3
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Nov 2025 to Dec 2025
    • Site details revised
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
An open-label study to evaluate the effect of TS-172 administration on pharmacokinetics in patients with hepatic impairment
Trial Details
NCT Number NCT07231029
Lead Sponsor Taisho Pharmaceutical Co., Ltd.
Conditions
(from sponsor)		 Patients With Mild or Moderate Hepatic Impairment
Enrollment 24 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov